Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis | Zendy

Theodora C van Tilborg | Zendy; Simone C Oudshoorn | Zendy; Marinus J.C. Eijkemans | Zendy; Monique H. Mochtar | Zendy; Ron J T van Golde | Zendy; Annemieke Hoek | Zendy; W. K. H. Kuchenbecker | Zendy; Kathrin Fleischer | Zendy; Jan Peter de Bruin | Zendy; Henk Groen | Zendy; Madelon van Wely | Zendy; Cornelis B. Lambalk | Zendy; Joop S.E. Laven | Zendy; Ben W. Mol | Zendy; Frank J. Broekmans | Zendy; Helen L. Torrance | Zendy; Carolien Koks | Zendy; Harold R Verhoeve | Zendy; Annemiek W. Nap | Zendy; Gabriëlle J Scheffer | Zendy; A Petra Manger | Zendy; Bendictus C Schoot | Zendy; G. J. E. Oosterhuis | Zendy; Alexander V Sluijmer | Zendy; Jaap Friederich | Zendy; Arie Verhoeff | Zendy; Marcel H A van Hooff | Zendy; Evert J. P. van Santbrink | Zendy; Egbert A Brinkhuis | Zendy; J Smeenk | Zendy; Janet Kwee | Zendy; Corry H de Koning | Zendy

Open Access

Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis

Author(s) -

Theodora C van Tilborg,

Simone C Oudshoorn,

Marinus J.C. Eijkemans,

Monique H. Mochtar,

Ron J T van Golde,

Annemieke Hoek,

W. K. H. Kuchenbecker,

Kathrin Fleischer,

Jan Peter de Bruin,

Henk Groen,

Madelon van Wely,

Cornelis B. Lambalk,

Joop S.E. Laven,

Ben W. Mol,

Frank J. Broekmans,

Helen L. Torrance,

Carolien Koks,

Harold R Verhoeve,

Annemiek W. Nap,

Gabriëlle J Scheffer,

A Petra Manger,

Bendictus C Schoot,

G. J. E. Oosterhuis,

Alexander V Sluijmer,

Jaap Friederich,

Arie Verhoeff,

Marcel H A van Hooff,

Evert J. P. van Santbrink,

Egbert A Brinkhuis,

J Smeenk,

Janet Kwee,

Corry H de Koning

Publication year - 2017

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/dex321

Subject(s) - medicine , ovarian reserve , antral follicle , live birth , cohort , dosing , follicle stimulating hormone , randomized controlled trial , gynecology , pregnancy , obstetrics , pregnancy rate , infertility , ovary , hormone , biology , luteinizing hormone , genetics

Is there a difference in live birth rate and/or cost-effectiveness between antral follicle count (AFC)-based individualized FSH dosing or standard FSH dosing in women starting IVF or ICSI treatment?

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research